These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

120 related articles for article (PubMed ID: 16149188)

  • 1. [Irbesartan induced acute hepatitis: one case].
    Péron JM; Robic MA; Bureau C; Vinel JP
    Gastroenterol Clin Biol; 2005; 29(6-7):747-8. PubMed ID: 16149188
    [No Abstract]   [Full Text] [Related]  

  • 2. [Irbesartan-induced acute hepatitis].
    Foruny Olcina JR; Moreira Vicente VF; Gómez García M; Morell Hita JL
    Gastroenterol Hepatol; 2004 Feb; 27(2):71-2. PubMed ID: 14733885
    [No Abstract]   [Full Text] [Related]  

  • 3. Could irbesartan trigger autoimmune cholestatic hepatitis?
    Annicchiarico BE; Siciliano M
    Eur J Gastroenterol Hepatol; 2005 Feb; 17(2):247-8. PubMed ID: 15674105
    [No Abstract]   [Full Text] [Related]  

  • 4. Cholestatic hepatitis related to use of irbesartan: a case report and a literature review of angiotensin II antagonist-associated hepatotoxicity.
    Andrade RJ; Lucena MI; Fernández MC; Vega JL; García-Cortés M; Casado M; Guerrero-Sanchez E; Pulido-Fernandez F
    Eur J Gastroenterol Hepatol; 2002 Aug; 14(8):887-90. PubMed ID: 12172412
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Anaemia in dialysis patients as a side-effect of sartanes.
    Schwarzbeck A; Wittenmeier KW; Hällfritzsch U
    Lancet; 1998 Jul; 352(9124):286. PubMed ID: 9690412
    [No Abstract]   [Full Text] [Related]  

  • 6. Comparison of the efficacy and safety of irbesartan and olmesartan in patients with hypertension (EARTH study).
    Morii J; Miura S; Shiga Y; Sugihara M; Arimura T; Sako H; Zhang B; Uehara Y; Saku K
    Clin Exp Hypertens; 2012; 34(5):342-9. PubMed ID: 22568596
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Irbesartan].
    Caballero E; Sádaba B; Azanza JR; Honorato J
    Rev Med Univ Navarra; 1998; 42(3):166-9. PubMed ID: 10420939
    [No Abstract]   [Full Text] [Related]  

  • 8. End-stage renal failure after irbesartan prescription in a diabetic patient with previously stable chronic renal insufficiency.
    Descombes E; Fellay G
    Ren Fail; 2000 Nov; 22(6):815-21. PubMed ID: 11104169
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Drug points: prolonged cholestasis associated with irbesartan.
    Hariraj R; Stoner E; Jader S; Preston DM
    BMJ; 2000 Sep; 321(7260):547. PubMed ID: 10968816
    [No Abstract]   [Full Text] [Related]  

  • 10. Efficacy of irbesartan, a receptor selective antagonist of angiotensin II, in reducing portal hypertension.
    Debernardi-Venon W; Barletti C; Alessandria C; Marzano A; Baronio M; Todros L; Saracco G; Repici A; Rizzetto M
    Dig Dis Sci; 2002 Feb; 47(2):401-4. PubMed ID: 11855558
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Clinical overview of irbesartan: a new angiotensin II receptor antagonist.
    Pouleur HG
    Am J Hypertens; 1997 Dec; 10(12 Pt 2):318S-324S. PubMed ID: 9438776
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Angioedema due to irbesartan].
    Rodríguez Conesa A; Matilla Fernández B; Gozalo Reques F
    Rev Esp Cardiol; 2001 Apr; 54(4):532. PubMed ID: 11282063
    [No Abstract]   [Full Text] [Related]  

  • 13. The KARTAN study: a postmarketing assessment of Irbesartan in patients with hypertension.
    Morales-Olivas FJ; Arístegui I; Estañ L; Rodicio JL; Moreno A; Gil V; Ferrón G; Velasco O;
    Clin Ther; 2004 Feb; 26(2):232-44. PubMed ID: 15038946
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Microalbuminuria in patients with hypertension and cardiovascular comorbidity, REAL observational study of treatment with Irbesartan/HCTZ].
    Tschöpe C; Tschöpe R; Unger T
    MMW Fortschr Med; 2006 Jun; 148(25):48. PubMed ID: 16859162
    [No Abstract]   [Full Text] [Related]  

  • 15. Losartan and angina pectoris.
    Ahmad S
    Tex Heart Inst J; 1995; 22(4):347-8. PubMed ID: 8605440
    [No Abstract]   [Full Text] [Related]  

  • 16. Irbesartan effects on renal function in patients with renal impairment and hypertension: a drug-withdrawal study.
    De Rosa ML; de Cristofaro A; Rossi M; Baiano A; Cardace P; Albanese L; Vigorito C
    J Cardiovasc Pharmacol; 2001 Sep; 38(3):482-9. PubMed ID: 11486253
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The long-term antihypertensive activity and tolerability of irbesartan with hydrochlorothiazide.
    Raskin P; Guthrie R; Flack J; Reeves R; Saini R
    J Hum Hypertens; 1999 Oct; 13(10):683-7. PubMed ID: 10516738
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Brief report: acute renal failure after losartan treatment in a patient with bilateral renal artery stenosis.
    Holm EA; Randløv A; Strandgaard S
    Blood Press; 1996 Nov; 5(6):360-2. PubMed ID: 8973754
    [No Abstract]   [Full Text] [Related]  

  • 19. Reversible ageusia associated with losartan.
    Schlienger RG; Saxer M; Haefeli WE
    Lancet; 1996 Feb; 347(8999):471-2. PubMed ID: 8618505
    [No Abstract]   [Full Text] [Related]  

  • 20. Headache in mild-to-moderate hypertension and its reduction by irbesartan therapy.
    Hansson L; Smith DH; Reeves R; Lapuerta P
    Arch Intern Med; 2000 Jun; 160(11):1654-8. PubMed ID: 10847258
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.